CFTR and cystic fibrosis: In recent years, CFTR modulators, compounds directly targeting the production and/or function of the malfunctioning CFTR protein to rectify the aberrant ion transport, have shown impressive effects on lung function, pulmonary exacerbation rates, nutritional status, general condition, and disease progression in CF patients with eligible CFTR mutations [5,6,7,8].